Quantitative Systematic Strategies LLC Kura Oncology, Inc. Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$15.42 - $21.72 $251,330 - $354,014	-16,299 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$20.85 - $29.88 $236,063 - $338,301	-11,322 Reduced 40.99%	16,299 $340,000
Q1 2021 May 06, 2021	BUY	$24.75 - $39.14 $41,530 - $65,676	1,678 Added 6.47%	27,621 $781,000
Q4 2020 Feb 09, 2021	BUY	$29.0 - $41.62 $440,916 - $632,790	15,204 Added 141.58%	25,943 $847,000
Q3 2020 Nov 09, 2020	BUY	$16.3 - $30.64 $175,045 - $329,042	10,739 New	10,739 $329,000
Q4 2018 Feb 12, 2019	SELL	$10.6 - $17.49 $142,188 - $234,610	-13,414 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $223,343 - $293,095	13,414 New	13,414 $235,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.